Page last updated: 2024-11-04

sulfisoxazole and Cardiac Hypertrophy

sulfisoxazole has been researched along with Cardiac Hypertrophy in 1 studies

Sulfisoxazole: A short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms.
sulfisoxazole : A sulfonamide antibacterial with an oxazole substituent. It has antibiotic activity against a wide range of gram-negative and gram-positive organisms.

Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
O'Connell, B1

Other Studies

1 other study available for sulfisoxazole and Cardiac Hypertrophy

ArticleYear
Pericarditis following meningococcic meningitis.
    American journal of diseases of children (1960), 1973, Volume: 126, Issue:2

    Topics: Ampicillin; Anemia; Cardiomegaly; Carrier State; Cerebrospinal Fluid; Dehydration; Drainage; Electro

1973